|
|
| | 4-Pyridinecarboxamide, 2-[(cyclopropylcarbonyl)amino]-N-[4-(4-fluorophenyl)-3-pyridinyl]- Basic information |
| | 4-Pyridinecarboxamide, 2-[(cyclopropylcarbonyl)amino]-N-[4-(4-fluorophenyl)-3-pyridinyl]- Chemical Properties |
| Boiling point | 565.3±50.0 °C(predicted) | | density | 1.411±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | pka | 11.47±0.70(predicted) |
| | 4-Pyridinecarboxamide, 2-[(cyclopropylcarbonyl)amino]-N-[4-(4-fluorophenyl)-3-pyridinyl]- Usage And Synthesis |
| Uses | GSK-3 inhibitor 6 (2) is a CNS penetrated GSK-3 inhibitor, with IC50 values of 29 nM and 24 nM for GSK-3α and GSK-3β, respectively[1]. | | References | [1] Surendra Reddy Gundam, et al. Synthesis and preliminary evaluation of novel PET probes for GSK-3 imaging. Sci Rep. 2024 Jul 10;14(1):15960. DOI:10.1038/s41598-024-65943-z |
| | 4-Pyridinecarboxamide, 2-[(cyclopropylcarbonyl)amino]-N-[4-(4-fluorophenyl)-3-pyridinyl]- Preparation Products And Raw materials |
|